null
Click on the links below to see details of all the clinical guidelines, published or in development, in this topic area.
Completed guidelines
Guidelines in development
Click on the links below to see details of all the interventional procedures, published or in development, in this topic area.
Completed interventional procedures
Cryosurgery for malignant endobronchial obstruction
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for mediastinal masses
Percutaneous radiofrequency ablation for primary and secondary lung cancers
Photodynamic therapy for advanced bronchial carcinoma
Photodynamic therapy for localised inoperable endobronchial cancer
Interventional procedures in development
- None
Click on the links below to see details of all the technology appraisals, published or in development, in this topic area.
Completed appraisals
Lung cancer (non-small cell, first line treatment) - pemetrexed
Lung cancer (non-small-cell) - bevacizumab (terminated appraisal)
Lung cancer (non-small-cell) - erlotinib
Lung cancer (non-small-cell) - pemetrexed
Lung cancer (non-small-cell, second line) - gefitinib (terminated appraisal)
Lung cancer (small-cell) - topotecan
Mesothelioma - pemetrexed disodium
Appraisals in development
Lung cancer (non-small-cell) - cetuximab
Lung cancer (non-small-cell) - pemetrexed (maintenance)
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (in combination with bevacizumab)
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy)
Lung cancer (non-small-cell, first line) - gefitinib
Lung cancer (non-small-cell, second line treatment) - vandetanib (suspended)